Wealth Enhancement Trust Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Buy
9,430
+1,033
+12% +$27K 0.03% 275
2026
Q1
$236K Sell
8,397
-2,584
-24% -$68.8K 0.03% 266
2025
Q4
$273K Buy
+10,981
New +$277K 0.03% 237

Other funds holding PFE

Wealth Enhancement Trust Services's PFE Position: Q2 2026 in Review

Wealth Enhancement Trust Services increased its Pfizer (PFE) stake by 12% in Q2 2026, buying an estimated $27K and bringing the position to 9,430 shares worth $227K. The position accounts for 0.03% of the portfolio, ranked #275.

Wealth Enhancement Trust Services first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $273K in Q4 2025. 2,263 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wealth Enhancement Trust Services held 9,430 shares of Pfizer worth $227K as of Q2 2026.
  • Wealth Enhancement Trust Services bought 1,033 Pfizer shares in Q2 2026, an estimated $27K.
  • Pfizer made up 0.03% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #275 holding.
  • Wealth Enhancement Trust Services first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Wealth Enhancement Trust Services's Pfizer position peaked at $273K in Q4 2025.
  • 2,263 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.